Gene expression profile of pemetrexed and oxaliplatin response in a phase II induction trial in locally advanced head and neck squamous cell carcinoma

Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-3052-4 ◽

2016 ◽

Vol 77 (6) ◽

pp. 1315-1319 ◽

Cited By ~ 3

Author(s):

Goshi Nishimura ◽

Takahide Taguchi ◽

Masahiro Takahashi ◽

Osamu Shiono ◽

Masanori Komatsu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Locally Advanced ◽

Randomized phase II trial of weekly paclitaxel, carboplatin, cetuximab (PCC) versus cetuximab, docetaxel, cisplatin, and fluorouracil (C-TPF) in previously untreated patients with locally advanced head and neck squamous cell carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps6102 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS6102-TPS6102 ◽

Cited By ~ 1

Author(s):

Erminia Massarelli ◽

Robert I. Haddad ◽

J. Jack Lee ◽

Adam S. Garden ◽

George R. Blumenschein ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Head ◽

Randomized Phase Ii

Cetuximab/Radiation Therapy (CET + RT) Versus Concomitant Chemoradiation Therapy (cCHT + RT) With or Without Induction Docetaxel/Cisplatin/5Fluorouracil (TPF) in Locally Advanced Head-and-Neck Squamous Cell Carcinoma (LASCCHN) – Preliminary Results on Toxicity of a Randomized, 2x2 Factorial, Phase II-III Study (NCT01086826)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.394 ◽

2012 ◽

Vol 84 (3) ◽

pp. S153 ◽

Cited By ~ 4

Author(s):

M. Ghi ◽

A. Paccagnella ◽

R. Orecchia ◽

S. Parisi ◽

F. Bertoni ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Locally Advanced ◽

Chemoradiation Therapy ◽

Advanced Head ◽

Concomitant Chemoradiation

Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma

International Journal of Clinical Oncology ◽

10.1007/s10147-016-0997-6 ◽

2016 ◽

Vol 21 (6) ◽

pp. 1030-1037 ◽

Cited By ~ 3

Author(s):

Susumu Nakahara ◽

Yukinori Takenaka ◽

Kazuhiko Ogawa ◽

Suetaka Nishiike ◽

Yoshifumi Yamamoto ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Adjuvant Chemotherapy ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Locally Advanced ◽

Blood Serum From Head and Neck Squamous Cell Carcinoma Patients Induces Altered MicroRNA and Target Gene Expression Profile in Treated Cells

Frontiers in Oncology ◽

10.3389/fonc.2018.00217 ◽

2018 ◽

Vol 8 ◽

Cited By ~ 6

Author(s):

Brittany Allen ◽

Augusto Schneider ◽

Berta Victoria ◽

Yury O. Nunez Lopez ◽

Mark Muller ◽

...

Keyword(s):

Gene Expression ◽

Squamous Cell Carcinoma ◽

Blood Serum ◽

Cell Carcinoma ◽

Head And Neck ◽

Gene Expression Profile ◽

Expression Profile ◽

Squamous Cell ◽

Target Gene ◽

Neck Squamous Cell Carcinoma

The gene expression profile of inflammatory, hypoxic and metabolic genes predicts the metastatic spread of human head and neck squamous cell carcinoma

Oral Oncology ◽

10.1016/j.oraloncology.2013.12.009 ◽

2014 ◽

Vol 50 (3) ◽

pp. 200-207 ◽

Cited By ~ 16

Author(s):

Florian Clatot ◽

Sophie Gouérant ◽

Sylvain Mareschal ◽

Marie Cornic ◽

Anca Berghian ◽

...

Keyword(s):

Gene Expression ◽

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Gene Expression Profile ◽

Expression Profile ◽

Squamous Cell ◽

Human Head ◽

Metabolic Genes

Abstract CT149: A Phase II study of Genexol-PM and cisplatin as induction chemotherapy in locally advanced head and neck squamous cell carcinoma

10.1158/1538-7445.am2019-ct149 ◽

2019 ◽

Author(s):

Keun-Wook Lee ◽

Bhumsuk Keam ◽

Jin-Soo Kim ◽

Se-Hoon Lee

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Locally Advanced ◽

A Phase II Study of Genexol‐PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

The Oncologist ◽

10.1634/theoncologist.2019-0070 ◽

2019 ◽

Vol 24 (6) ◽

pp. 751 ◽

Cited By ~ 2

Author(s):

Bhumsuk Keam ◽

Keun‐Wook Lee ◽

Se‐Hoon Lee ◽

Jin‐Soo Kim ◽

Jin Ho Kim ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Locally Advanced ◽

Carboplatin, Tegafur-uracil, Leucovorin and Concurrent Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma. Results of the 2003–01 Phase II GORTEC Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2007.07.1569 ◽

2007 ◽

Vol 69 (3) ◽

pp. S423

Author(s):

M. Fesneau ◽

S. Chapet ◽

L. Martin ◽

P. Pommier ◽

M. Alfonsi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Locally Advanced ◽

Advanced Head ◽

Concurrent Radiotherapy

Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma

Head & Neck ◽

10.1002/hed.24313 ◽

2016 ◽

Vol 38 (S1) ◽

pp. E1770-E1776 ◽

Cited By ~ 11

Author(s):

Min Yao ◽

Charles Woods ◽

Pierre Lavertu ◽

Pingfu Fu ◽

Michael Gibson ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Locally Advanced ◽

Intensity Modulated Radiotherapy ◽

Advanced Head ◽

Intensity Modulated